[1] Boucher BJ. Is vitamin D status relevant to metabolic syndrome? Dermato-endocrinology. 2012;4(2):212-24.
[2] Bian S, Gao Y, Zhang M, Wang X, Liu W, Zhang D, et al. Dietary nutrient intake and metabolic syndrome risk in Chinese adults: a case–control study. Nutrition journal. 2013;12(1):1.
[3] Robinson LE, Graham TE. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Canadian journal of applied physiology. 2004;29(6):808-29.
[4] Heshmat R, Mohammad K, Majdzadeh S, Forouzanfar M, Bahrami A, Ranjbar Omrani G. Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iran J Public Health. 2008;37(suppl).
[5] Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. The American journal of clinical nutrition. 2004;79(5):820-5.
[6] Hossein-Nezhad A, Khoshniat N, Maghbooli M, Karimi Z, Mirzaei F, Hosseini A, et al. Relationship between serum vitamin D concentration and metabolic syndrome among Iranian adults population. DARU Journal of Pharmaceutical Sciences. 2015(1):1-5.
[7] Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. The American journal of clinical nutrition. 2000;72(3):690-3.
[8] Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public health. 2004;4(1):1.
[9] Khorvash F, Mottaghi T, Askari G, Maracy MR, Ghiasvand R, Maghsoudi Z, et al. The association between serum vitamin d levels with general and abdominal obesity among patients with migraine. International journal of preventive medicine. 2013;4(Suppl 2):S313-s7.
[10] Vanlint S. Vitamin D and Obesity. Nutrients. 2013;5(3):949-56.
[11] Abbas MA. Physiological functions of Vitamin D in adipose tissue. The Journal of steroid biochemistry and molecular biology. 2017;165:369-81.
[12] Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, Dehghani S, et al. A 12-week double-blind randomized clinical trial of vitamin D 3 supplementation on body fat mass in healthy overweight and obese women. Nutrition journal. 2012;11(1):1-8.
[13] Austin J, Marks D. Hormonal Regulators of Appetite. International Journal of Pediatric Endocrinology. 2009;2009.
[14] Baura GD, Foster D, Porte Jr D, Kahn S, Bergman R, Cobelli C, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. Journal of Clinical Investigation. 1993;92(4):1824.
[15] Heiston EM, Eichner NZ, Gilbertson NM, Malin SK. Exercise improves adiposopathy, insulin sensitivity and metabolic syndrome severity independent of intensity. Experimental physiology. 2020;105(4):632-40.
[16] Rohani H, Azali ak, helalizadeh m. effect of aerobic training on overall metabolic risk and indices levels in patients with metabolic syndrome: a meta-analysis study. 2016.
[17] Beaulieu K, Oustric P, Finlayson G. The impact of physical activity on food reward: Review and conceptual synthesis of evidence from observational, acute, and chronic exercise training studies. Current obesity reports. 2020;9(2):63-80.
[18] Azali -Alamdari K, Saberi Y. The Effects of Aerobic Training on Blood ACHE and BCHE Activities and cardiometabolic Risk Factors Level in Midlife Women. Journal of Applied Exercise Physiology. 2019;15(29):105-18.
[19] Azizi M, Ebrahimi A, Tahmasebi W, Hoseini R. The effect of eight weeks high intensity interval training with alginate sodium and lipid profile on PYY levels in men with metabolic syndrome. Journal of Applied Health Studies in Sport Physiology. 2018;5(1):18-27.
[20] Azali Alamdari k, Armanfar M, Khodaei O. The effect of high intensity interval training on serum adiponectin, insulin resistance and markers of metabolic syndrome in men with metabolic syndrome. Journal of Applied Health Studies in Sport Physiology. 2018;5(1):69-76.
[21] Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes care. 2005;28(12):2926-32.
[22] Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear Relations of Blood Pressure to Cognitive Function The Baltimore Longitudinal Study of Aging. Hypertension. 2005;45(3):374-9.
[23] Azali Alamdari K, Azaryan S, Ghorbanzadeh B, Khoshnevis F. Figure rating and body appreciation in sedentary and those women present in sport activities from Tabriz City. Journal of Health Promotion Management. 2016;5(3):1-14.
[24] Wang Y, Si S, Liu J, Wang Z, Jia H, Feng K, et al. The Associations of Serum Lipids with Vitamin D Status. PLoS ONE. 2016;11(10).
[25] Cho H, Kang H, Choi S, Ju Y, Lee H, Park H. The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biological & pharmaceutical bulletin. 2005;28(8):1418.
[26] Yin X, Sun Q, Zhang X, Lu Y, Sun C, Cui Y, et al. Serum 25 (OH) D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese population. Nutrition Journal. 2012;11(1):68.
[27] Faridi K, Zhao D, Martin S, Lupton J, Jones S, Guallar E, et al. Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study. Nutrition (Burbank, Los Angeles County, Calif). 2017;38:85.
[28] Pirro M, Manfredelli M, Helou R, Scarponi A, Schillaci G, Bagaglia F, et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. Journal of atherosclerosis and thrombosis. 2012;19(10):924.
[29] Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Medicine. 2014;44(2):211-21.
[30] Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. European journal of nutrition. 2009;48(6):349-54.
[31] Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, et al. Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes care. 2010;33(6):1379-81.
[32] Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35(1):11-7.
[33] Delvin E, Souberbielle J-C, Viard J-P, Salle B. Role of vitamin D in acquired immune and autoimmune diseases. Critical reviews in clinical laboratory sciences. 2014;51(4):232-47.
[34] Jelleyman C, Yates T, O'Donovan G, Gray LJ, King JA, Khunti K, et al. The effects of high‐intensity interval training on glucose regulation and insulin resistance: a meta‐analysis. Obesity reviews. 2015;16(11):942-61.
[35] al SISBBGe. Concurrent resistance and aerobic training as protection against heart disease Cardiovascular Journal of Africa. 2010;21(4):196-9.
[36] Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. Journal of hypertension. 2011;29(4):636-45.
[37] Qi D, Nie X, Cai J. The effect of vitamin D supplementation on hypertension in non-CKD populations: A systemic review and meta-analysis. International Journal of Cardiology. 2017;227:177-86.
[38] Kunutsor S, Laukkanen J. Circulating active serum calcium reduces the risk of hypertension. European journal of preventive cardiology. 2017;24(3):239.
[39] Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010;55(5):1283-8.
[40] Jeong HY, Park KM, Lee MJ, Yang DH, Kim SH, Lee S-Y. Vitamin D and Hypertension. Electrolytes & Blood Pressure. 2017;15(1):1-11.
[41] Andrukhova O, Slavic S, Zeitz U, Riesen SC, Heppelmann MS, Ambrisko TD, et al. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Molecular Endocrinology. 2014;28(1):53-64.
[42] Börjesson M, Onerup A, Lundqvist S, Dahlöf B. Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs. British journal of sports medicine. 2016;50(6):356.
[43] Wallace JP. Exercise in hypertension. Sports Medicine. 2003;33(8):585-98.
[44] Hagberg J, Park J, Brown M. The role of exercise training in the treatment of hypertension: an update. Sports medicine (Auckland, NZ). 2000;30(3):193.
[45] Ross R, Hudson R, Stotz PJ, Lam M. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial. Annals of internal medicine. 2015;162(5):325-34.
[46] Lotta LA, Gulati P, Day FR, Payne F, Ongen H, Van De Bunt M, et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nature genetics. 2017;49(1):17.
[47] Caudwell P, Gibbons C, Hopkins M, King N, Finlayson G, Blundell J. No sex difference in body fat in response to supervised and measured exercise. Medicine and science in sports and exercise. 2013;45(2):351-8.
[48] King NA, Caudwell PP, Hopkins M, Stubbs JR, Naslund E, Blundell JE. Dual-process action of exercise on appetite control: increase in orexigenic drive but improvement in meal-induced satiety. The American journal of clinical nutrition. 2009;90(4):921-7.
[49] Zarineh F, Avandi SM, Ebrahimi M. The effect of eight weeks high-intensity interval training with milk supplementation on Appetite and Body Composition in obese women. Journal of Applied Health Studies in Sport Physiology. 2017;4(1):82-90.
[50] Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908-13.
[51] Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M. Protein, weight management, and satiety. The American journal of clinical nutrition. 2008;87(5):1558S-61S.
)